Marlena Habal

877 total citations
33 papers, 530 citations indexed

About

Marlena Habal is a scholar working on Surgery, Transplantation and Biomedical Engineering. According to data from OpenAlex, Marlena Habal has authored 33 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 14 papers in Transplantation and 11 papers in Biomedical Engineering. Recurrent topics in Marlena Habal's work include Transplantation: Methods and Outcomes (17 papers), Renal Transplantation Outcomes and Treatments (14 papers) and Mechanical Circulatory Support Devices (11 papers). Marlena Habal is often cited by papers focused on Transplantation: Methods and Outcomes (17 papers), Renal Transplantation Outcomes and Treatments (14 papers) and Mechanical Circulatory Support Devices (11 papers). Marlena Habal collaborates with scholars based in United States, Canada and France. Marlena Habal's co-authors include Maryjane Farr, Nir Uriel, Gabriel Sayer, Susan Restaino, Kevin J. Clerkin, Yoshifumi Naka, F. Latif, Koji Takeda, A.R. Garan and Gary Levy and has published in prestigious journals such as Journal of Virology, Frontiers in Immunology and Transplantation.

In The Last Decade

Marlena Habal

26 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlena Habal United States 13 215 168 106 98 69 33 530
Srinivas Bollineni United States 11 54 0.3× 232 1.4× 71 0.7× 34 0.3× 94 1.4× 46 438
Cristina Berastegui Spain 16 171 0.8× 386 2.3× 61 0.6× 53 0.5× 115 1.7× 68 682
Jennifer L. Alejo United States 10 143 0.7× 170 1.0× 20 0.2× 11 0.1× 206 3.0× 33 459
Oscar K. Serrano United States 16 68 0.3× 322 1.9× 20 0.2× 36 0.4× 128 1.9× 83 708
Bianca Zukunft Germany 10 109 0.5× 207 1.2× 43 0.4× 82 0.8× 225 3.3× 18 490
Jungwon Hyun South Korea 14 241 1.1× 84 0.5× 14 0.1× 79 0.8× 93 1.3× 49 513
Florence Daviet France 13 88 0.4× 88 0.5× 126 1.2× 31 0.3× 25 0.4× 25 431
Marcos Mills United States 4 314 1.5× 276 1.6× 68 0.6× 31 0.3× 5 0.1× 13 559
Scott C. Roberts United States 12 125 0.6× 61 0.4× 14 0.1× 78 0.8× 6 0.1× 42 598
Jakob Gubenšek Slovenia 13 85 0.4× 220 1.3× 15 0.1× 134 1.4× 57 0.8× 55 556

Countries citing papers authored by Marlena Habal

Since Specialization
Citations

This map shows the geographic impact of Marlena Habal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlena Habal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlena Habal more than expected).

Fields of papers citing papers by Marlena Habal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlena Habal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlena Habal. The network helps show where Marlena Habal may publish in the future.

Co-authorship network of co-authors of Marlena Habal

This figure shows the co-authorship network connecting the top 25 collaborators of Marlena Habal. A scholar is included among the top collaborators of Marlena Habal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlena Habal. Marlena Habal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gimferrer, Idoia, Marlena Habal, Sebastiaan Heidt, et al.. (2026). Sensitization in organ transplantation: Assessment of Risk (STAR) 2025 meeting group report. American Journal of Transplantation.
2.
Bowring, Mary G., Jessica M. Ruck, Omar Saeed, et al.. (2025). Potential pool of cardiothoracic organs from donors with HIV. The Journal of Heart and Lung Transplantation. 45(3). 460–467.
3.
Coutance, Guillaume, Anita S. Chong, & Marlena Habal. (2025). Novel pretransplant desensitization strategies in heart transplantation. JHLT Open. 8. 100242–100242.
4.
Habal, Marlena. (2025). Immunosuppression Management in Heart Transplantation. Methodist DeBakey Cardiovascular Journal. 21(3). 40–50.
5.
Bae, Sunjae, Alexandra T. Strauss, Bonnie E. Lonze, et al.. (2024). Generalizability of kidney transplant data in electronic health records — The Epic Cosmos database vs the Scientific Registry of Transplant Recipients. American Journal of Transplantation. 25(4). 744–755. 1 indexed citations
6.
Xiao, Yao, Andreas Schroeter, Tomohisa Matsunaga, et al.. (2023). Sex as a biological variable: Mechanistic insights and clinical relevance in solid organ transplantation. American Journal of Transplantation. 23(11). 1661–1672. 3 indexed citations
7.
Chong, Anita S. & Marlena Habal. (2022). From bench to bedside: reversing established antibody responses and desensitization. Current Opinion in Organ Transplantation. 27(5). 376–384.
8.
Jennings, Douglas L., F. Latif, Susan Restaino, et al.. (2022). PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis. Heart Failure Reviews. 28(1). 149–156. 10 indexed citations
9.
Topkara, Veli K., Kevin J. Clerkin, J. Fried, et al.. (2021). Exception Status Listing in the New Adult Heart Allocation System: A New Solution to an Old Problem?. Circulation Heart Failure. 14(6). e007916–e007916. 21 indexed citations
10.
Habal, Marlena. (2021). Current Desensitization Strategies in Heart Transplantation. Frontiers in Immunology. 12. 702186–702186. 12 indexed citations
11.
Clerkin, Kevin J., Jan M. Griffin, J. Fried, et al.. (2021). How can we better inform our patients about post‐heart transplantation survival? A conditional survival analysis. Clinical Transplantation. 35(11). e14449–e14449.
12.
Purpura, Lawrence J., Michelle Chang, Medini K. Annavajhala, et al.. (2021). Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient. American Journal of Transplantation. 22(2). 649–653. 7 indexed citations
13.
Jain, Rashmi, Marlena Habal, Susan Restaino, et al.. (2020). De-Novo Human Leukocyte Antigen Allosensitization on HeartMate 3 versus HeartMate II Left Ventricular Assist Device Recipients. The Journal of Heart and Lung Transplantation. 39(4). S16–S16. 1 indexed citations
14.
Farr, Maryjane, Douglas L. Jennings, Geo Şerban, et al.. (2020). Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition. American Journal of Transplantation. 20(12). 3620–3630. 33 indexed citations
15.
16.
Habal, Marlena, Kelly Axsom, & Maryjane Farr. (2018). Advanced Therapies for Advanced Heart Failure in Women. Heart Failure Clinics. 15(1). 97–107. 13 indexed citations
17.
Habal, Marlena, L. Truby, Masahiko Ando, et al.. (2018). VA‐ECMO for cardiogenic shock in the contemporary era of heart transplantation: Which patients should be urgently transplanted?. Clinical Transplantation. 32(9). e13356–e13356. 5 indexed citations
18.
Habal, Marlena & A.R. Garan. (2017). Long-term management of end-stage heart failure. Best Practice & Research Clinical Anaesthesiology. 31(2). 153–166. 21 indexed citations
19.
Habal, Marlena, et al.. (2011). How Aware of Advanced Care Directives Are Heart Failure Patients, and Are They Using Them?. Canadian Journal of Cardiology. 27(3). 376–381. 14 indexed citations
20.
Colman, Robert W., et al.. (1976). Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin.. PubMed. 82(1). 25–42. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Srinivas Bollineni Breakdown of academic impact, for papers by Cristina Berastegui Breakdown of academic impact, for papers by Jennifer L. Alejo Breakdown of academic impact, for papers by Oscar K. Serrano Breakdown of academic impact, for papers by Bianca Zukunft Breakdown of academic impact, for papers by Jungwon Hyun Breakdown of academic impact, for papers by Florence Daviet Breakdown of academic impact, for papers by Marcos Mills Breakdown of academic impact, for papers by Scott C. Roberts Breakdown of academic impact, for papers by Jakob Gubenšek
Rankless by CCL
2026